| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/28/2004 | EP1411984A2 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 04/28/2004 | EP1411949A2 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors |
| 04/28/2004 | EP1411948A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 04/28/2004 | EP1411945A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1411944A1 Sulfonamide derivatives as gamma secretase inhibitors |
| 04/28/2004 | EP1411942A1 Substituted anilinic piperidines as mch selective antagonists |
| 04/28/2004 | EP1411941A2 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1411940A1 Bridged piperidine derivatives as melanocortin receptor agonists |
| 04/28/2004 | EP1411933A1 Alpha-ketoamide derivatives as cathepsin k inhibitors |
| 04/28/2004 | EP1411929A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/28/2004 | EP1411928A1 Viral polymerase inhibitors |
| 04/28/2004 | EP1244642B1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
| 04/28/2004 | EP1230237B1 Magnesium omeprazole |
| 04/28/2004 | EP1228062B1 Herbicidal 2-aryloxy-6-fluoroalkylthioalk(en)yloxy-pyridines |
| 04/28/2004 | EP1208096B1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
| 04/28/2004 | EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity |
| 04/28/2004 | EP0946544B1 Heterocyclyluracil |
| 04/28/2004 | EP0888271B1 Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants |
| 04/28/2004 | CN1492863A Heterocyclylalkylindole or azaindole compounds as 5-hydroxytryptamine-6 ligands |
| 04/28/2004 | CN1492860A 喹唑啉衍生物 Quinazoline derivatives |
| 04/28/2004 | CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 04/28/2004 | CN1491945A Process for preparing human immunodeficiency virus (HIV) proteinase inhibitor |
| 04/28/2004 | CN1491944A 5-amino-8-methoxy quinolone carboxylic acid derivatives and its preparation |
| 04/28/2004 | CN1491941A Heterobicyclic sulfonamide derivative and sulfonic ester derivative |
| 04/28/2004 | CN1147486C 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles |
| 04/28/2004 | CN1147485C Indoline derivatives useful as 5-HT-2C receptor antagonists |
| 04/28/2004 | CN1147476C Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 04/28/2004 | CN1147471C Renin inhibitors |
| 04/27/2004 | US6727364 Antiinflammatory agents |
| 04/27/2004 | US6727275 Pyrrolidinone derivatives |
| 04/27/2004 | US6727273 Therapy for osteoporosis, anticancer agents |
| 04/27/2004 | US6727264 Substituted anilinic piperidines as MCH selective antagonists |
| 04/27/2004 | US6727257 Hypotensive agents for intraocular pressure; anticholesterol agents; relaxing urinary tract tissue; benign prostatic hyperplasia, impotency, and cardiovascular disorders; antiarrhythmia agents |
| 04/27/2004 | US6727255 Brain, nervous system and psychological disorders |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727248 Substituted quinolinecarboxamides as antiviral agents |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | US6727237 Alkylating 5-nitroindole with 6-bromohexyl acetate to form a 6-(N-(5-nitroindolyl)) hexyl acetate, hydrolyzing to form alcohol of above ester, estrifying with nicotinic acid, and methylating the intermediate |
| 04/27/2004 | US6727041 Optical recording media |
| 04/27/2004 | CA2136745C Heterocyclically disubstituted sulphonylamino(thio)carbonyl compounds |
| 04/23/2004 | CA2445817A1 Novel derivatives of imidazoline, process for their preparation and pharmaceutical compositions containing them |
| 04/22/2004 | WO2004033632A2 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace) |
| 04/22/2004 | WO2004033446A1 Protein tyrosine kinase inhibitors |
| 04/22/2004 | WO2004033445A1 4-amino-azepan-3-one compounds as cathepsin k inhibitors useful in the treatment of osteoporosis |
| 04/22/2004 | WO2004033444A1 Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 04/22/2004 | WO2004033436A1 Sulfonylbenzodiazepinone acetamides as bradykinin antagonists |
| 04/22/2004 | WO2004033434A1 Pyrazole compounds for treatment of neurodegenerative disorders |
| 04/22/2004 | WO2004033432A1 Novel pyrazole compounds having antifungal activity |
| 04/22/2004 | WO2004033431A2 Hydroxypyrazoles for use against metabolic-related disorders |
| 04/22/2004 | WO2004033428A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 04/22/2004 | WO2004033427A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| 04/22/2004 | WO2004033426A2 Heteroaryl propyl-piperazines and heteroaryl propyl-piperidines serving as dopaminergic and serotoninergic agents |
| 04/22/2004 | WO2004033418A2 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists |
| 04/22/2004 | WO2004032929A2 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer’s disease |
| 04/22/2004 | WO2004032908A2 Method of inhibiting angiogenesis |
| 04/22/2004 | WO2004032848A2 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 04/22/2004 | WO2004032846A2 Triazolone and triazolethione derivatives |
| 04/22/2004 | WO2004032834A2 Thrombin inhibitors |
| 04/22/2004 | WO2004022544A8 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 04/22/2004 | WO2004020410A3 Dihydropyridinone derivatives as hne inhibitors |
| 04/22/2004 | WO2004018431A3 Novel phenanthridines |
| 04/22/2004 | WO2004016597A3 Protein kinase inhibitors and uses thereof |
| 04/22/2004 | WO2004014300A3 Tyrosine kinase inhibitors |
| 04/22/2004 | WO2004005407A3 Tetra-azapentamethine and use thereof for dyeing keratinous fibers |
| 04/22/2004 | WO2004002984A3 Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules |
| 04/22/2004 | WO2003078403A3 Derives d’aminoindazoles comme inhibiteurs de proteine-kinase |
| 04/22/2004 | WO2003072106A3 Use of tyrosine kinase inhibitors for treating substance use disorders |
| 04/22/2004 | WO2003005999A8 Methods of treating cytokine mediated diseases |
| 04/22/2004 | WO2002098857A8 New indole derivatives with 5-ht6 receptor affinity |
| 04/22/2004 | WO2002074767A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074752A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074748A8 Metalloproteinase inhibitors |
| 04/22/2004 | US20040077877 Jun n-terminal kinase inhibitors |
| 04/22/2004 | US20040077869 Process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
| 04/22/2004 | US20040077865 Making 1-amino-6-nitroisoquinoline by reacting beta-(dimethylamino)-2-cyano-5-nitro-styrene with lithium hexamethyldisilazane or reacting said styrene compound with 2,4-dimethoxybenzylamine and then with anisole |
| 04/22/2004 | US20040077860 Quinoxaline derivative; light-emitting diode, light-emitting electrochemical cell, or a photodetector |
| 04/22/2004 | US20040077853 2-amino-6-(2,4,5-substituted-phenyl)-pyridines |
| 04/22/2004 | US20040077851 Receptor selective cannabimimetic aminoalkylindoles |
| 04/22/2004 | US20040077798 Thermosetting resin compositions containing maleimide and/or vinyl compounds |
| 04/22/2004 | US20040077709 Neuronal death inhibitors |
| 04/22/2004 | US20040077707 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 04/22/2004 | US20040077706 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome |
| 04/22/2004 | US20040077701 Pyrazole derivates for treatment of osteoporosis, breast and endometrial cancers, atherosclerosis, and Alzheimer*s disease |
| 04/22/2004 | US20040077699 Substituted triazole diamine derivatives as kinase inhibitors |
| 04/22/2004 | US20040077690 Anticoagulants; cardiovascular and brain disorders |
| 04/22/2004 | US20040077689 Abc expression promoters |
| 04/22/2004 | US20040077688 Treating psoriasis, gastroesophageal reflux, Zollinger-Ellison Syndrome; antiulcer and antisecretory agents |
| 04/22/2004 | US20040077686 Inhibition of cyclooxygenase-2 activity |
| 04/22/2004 | US20040077685 Analogs of thalidomide as potential angiogenesis inhibitors |
| 04/22/2004 | US20040077684 Piperidinyl compounds that selectively bind integrins |
| 04/22/2004 | US20040077671 Sorbitol dehydrogenase inhibitors |
| 04/22/2004 | US20040077670 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/22/2004 | US20040077668 Compounds, compositins, and methods |
| 04/22/2004 | US20040077667 Quinazolinone derivatives |
| 04/22/2004 | US20040077656 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents |
| 04/22/2004 | US20040077655 Piperazine derivatives for treatment of bacterial infections |
| 04/22/2004 | US20040077654 Anticholesterol agents; cardiovascular disorders |
| 04/22/2004 | US20040077653 GABAA (gamma-aminobutyric acid) receptor modulators; anxiolytic, antidepresant agents; attention deficit disorder, Alzheimer*s disease treatment; central nervous systmem disorders |
| 04/22/2004 | US20040077650 Cannabinoid receptor ligands and uses thereof |
| 04/22/2004 | US20040077648 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |